Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Operating Expenses | 8,788 | 11,261 | 10,040 | 11,051 | 10,634 |
| Operating Income | -8,788 | -11,261 | -10,040 | -11,051 | -10,634 |
| Interest Expense | 172 | 0 | 0 | 0 | 0 |
| Other Income | 21 | 13 | 23 | 117 | 205 |
| Pre-tax Income | -8,940 | -11,247 | -10,017 | -10,933 | -10,429 |
| Income Tax | 264 | 264 | 264 | 144 | 144 |
| Net Income Continuous | -9,204 | -11,512 | -10,281 | -11,077 | -10,573 |
| Minority Interests | -414 | -595 | -513 | N/A | N/A |
| Net Income | $-8,790 | $-10,917 | $-9,768 | $-10,790 | $-10,573 |
| EPS Basic Total Ops | -0.80 | -1.27 | -1.30 | -1.61 | -1.57 |
| EPS Basic Continuous Ops | -0.84 | -1.34 | -1.37 | -1.55 | -1.52 |
| EPS Diluted Total Ops | -0.80 | -1.27 | -1.30 | -1.61 | -1.57 |
| EPS Diluted Continuous Ops | -0.84 | -1.34 | -1.37 | -1.55 | -1.52 |
| EPS Diluted Before Non-Recurring Items | -0.80 | -1.27 | -1.30 | N/A | -1.50 |
| EBITDA(a) | $-8,747 | $-11,205 | $-9,985 | $-10,997 | $-10,581 |